Growth Metrics

Orthopediatrics (KIDS) Liabilities and Shareholders Equity (2016 - 2026)

Orthopediatrics has reported Liabilities and Shareholders Equity over the past 11 years, most recently at $502.2 million for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity rose 6.79% year-over-year to $502.2 million; the TTM value through Mar 2026 reached $2.0 billion, up 7.75%, while the annual FY2025 figure was $508.6 million, 7.49% up from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 was $502.2 million at Orthopediatrics, down from $508.6 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $508.6 million in Q4 2025 and troughed at $301.0 million in Q1 2022.
  • A 5-year average of $443.0 million and a median of $437.2 million in 2024 define the central range for Liabilities and Shareholders Equity.
  • On a YoY basis, Liabilities and Shareholders Equity climbed as much as 41.65% in 2022 and fell as far as 3.94% in 2022.
  • Year by year, Liabilities and Shareholders Equity stood at $427.7 million in 2022, then grew by 2.58% to $438.7 million in 2023, then increased by 7.86% to $473.2 million in 2024, then grew by 7.49% to $508.6 million in 2025, then dropped by 1.27% to $502.2 million in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for KIDS at $502.2 million in Q1 2026, $508.6 million in Q4 2025, and $493.5 million in Q3 2025.